BLS Polymers IPO: GMP, Valuation and Raw Material Risks

Issue structure and price band

BLS Polymers is launching a ₹255 crore book-built initial public offering. The issue is entirely a fresh issue of 1.70 crore equity shares. There is no offer for sale in the transaction. The price band is ₹142 to ₹150 per share. At the upper end, the issue size works out to about ₹255 crore. The company is expected to list on both the BSE and NSE. Social-media discussions have focused on possible listing gains as well as the business risks behind the offer. Investors should separate unofficial market indications from the company’s operating fundamentals.

Timetable investors are tracking

The issue closes on October 29, 2026, according to the shared timetable. Allotment is expected to be finalised on October 30. Shares are scheduled to list on November 3. The schedule follows SEBI’s T+3 listing framework cited in the discussions. These dates matter for applicants assessing the period for which funds may remain blocked. They do not determine the eventual listing price. Demand during the book-building process remains more relevant to allotment and pricing outcomes. Investors should also verify dates through the final issue documents and their broker platforms.

What the company does

BLS Polymers is described as a Goa-based producer of polymer compounds. Its products are used to sheath and insulate cables and to coat oil, gas and water pipes. The company also trades polymer resin. Demand is linked to power, telecom, railways, water, and oil and gas activity. Wire and cable compounds account for a substantial part of the business, according to the discussion. That concentration means a slowdown in this segment could affect sales and profit. The company currently operates one manufacturing facility in Goa. The facility has 11 machines, making operational continuity a material consideration.

IPO proceeds and expansion plans

The fresh issue will provide capital to the company rather than an exit to existing shareholders. BLS Polymers plans to use ₹77.56 crore for capital expenditure. The stated purpose is to expand the manufacturing facility and increase capacity for certain existing products. Remaining proceeds are also intended for working-capital requirements. Existing capacity headroom and the proposed expansion could support higher production. However, the expansion is described as large relative to the current plant and mostly unbuilt. Its benefits depend on timely execution, utilisation and demand for the added capacity. Higher earnings from the project would be needed to offset the dilution from new shares.

Revenue mix and earnings trend

Online commentary points to a changing mix between manufactured and traded sales. Trading contributed 32% of FY26 revenue, compared with 14% in FY24. Manufactured sales reportedly declined from ₹255 crore in FY24 to ₹238 crore in FY26. Total income grew 11.68% in FY25 and 5.26% in FY26. FY26 profit rose 27.77%, with the discussion attributing much of the increase to improved margins rather than stronger sales. The company’s return on equity was stated to exceed 30%. EBITDA margins have also expanded over the past three years, according to the supplied context. The revenue mix and pace of sales growth remain important areas for investors to monitor after listing.

Valuation needs careful reading

Some online posts have questioned the valuation figures presented for the offer. At ₹150 per share, the post-issue market capitalisation was estimated at about ₹930.48 crore. That calculation uses roughly 6.20 crore post-issue shares. Using FY25 profit of ₹21.14 crore, the implied diluted price-to-earnings multiple is near 44 times. Using FY26 profit of ₹27.01 crore, the discussion estimated EPS of about ₹4.35 and a price-to-earnings multiple near 34 times. These calculations differ from a cited P/E of 22.73 and a cited post-issue EPS of ₹6.60. The mismatch has led commentators to advise caution when comparing headline valuation metrics. Investors should review the final prospectus figures and use consistent post-issue share counts.

GMP signals remain unofficial

Grey market premium, or GMP, has been a major part of the BLS Polymers IPO discussion. Figures shared on October 26 and October 27 ranged from ₹32 to ₹40 per share. At the ₹150 upper price band, these premiums imply indicative prices between ₹182 and ₹190. That translates into an indicated gain of roughly 21% to 27%, depending on the GMP quoted. These are not exchange-traded prices or guaranteed returns. GMP can change before shares begin trading. It may also fail to reflect actual demand or the broader market mood on listing day. Investors seeking listing gains should treat it only as an unofficial sentiment indicator.

Operating risks behind the offer

SBI Securities flagged customer and supplier concentration, raw-material volatility and reliance on one facility as key risks. The top 10 customers generated 64.44% of FY25 revenue, according to one cited source. Losing a large account could create a meaningful revenue gap and disrupt production planning. The business imports raw materials, exposing margins to commodity prices and currency movements. Discussions also cite dependence on Saudi Arabia for export revenue. Supplier discounts were identified as a factor supporting profit, adding another area to track. Tariff changes, plastic-waste rules and high working-capital needs may also affect operations. Cyclical spending on cables and pipelines could influence both volumes and pricing.

Listing-gain case versus medium-term case

The IPO may appeal to investors looking for a possible listing gain or a medium-term opportunity. Supportive factors cited include return ratios above 30%, expanding margins and capacity expansion plans. Government enlistments were also described as a possible quality gate for larger infrastructure buyers. Yet none of these factors assures growth or listing performance. The changing sales mix, slower revenue growth and valuation debate limit comfort at the offer price. A single-plant disruption would affect the entire manufacturing operation. Raw-material costs and currency moves can pressure margins even if volumes remain stable. Based on the risks highlighted in the discussion, the offer has been characterised as a moderate-to-high-risk proposition.